Reema R Mody (Reema Mody)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Atrial Fibrillation

Placebo Controlled

Cardiovascular Risk Factors

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Reema R Mody, Kellie L Meyer, Jennifer M Ward, Ken B O'Day
Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
William J Valentine, Meredith Hoog, Reema R Mody, Mark Belger, Richard F Pollock
Long-term cost-effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States. Diabetes, obesity & metabolism (2023)
Radhika Nair, Reema R Mody, Maria Yu, Stuart Cowburn, Manige Konig, Todd Prewitt
Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 13 (11-12) (2022)